The abstract is read at the publisher; the summary is JClub's.
In freely behaving mice, TAAR1 agonists ulotaront and RO5166017 mitigated PCP-induced locomotor and striatal MSN calcium dynamics, showing a similar movement-linked increase in the PCP state across D1 and D2 MSNs.
- Why it matters: Schizophrenia involves striatal hyperdopaminergia and glutamatergic dysregulation, but how TAAR1 agonists alter postsynaptic striatal neuronal dynamics and behavior under psychosis-like conditions is unclear.
- What they did: Mice received TAAR1 agonists (ulotaront, RO5166017) and were imaged for in vivo calcium dynamics in D1- and D2-receptor expressing MSNs during normal and PCP-induced psychosis-like states, alongside comparisons to haloperidol and clozapine.
- The result: Both TAAR1 agonists reduced PCP-linked changes in MSN activity and spatiotemporal dynamics with state dependence, whereas haloperidol and clozapine produced similar behavioral effects but distinct, less state-dependent striatal MSN modulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.